FBDT
FBDTCIK 0001892704
No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (IREN 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade FBDT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 28, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Net revenues | 95,353 | 95,219 | 361,357 | 110,905 |
| Cost of revenues | 605,866 | 592,348 | 1,235,716 | 919,844 |
| Net loss associated with liquidation of raw materials | — | 298,771 | — | 684,960 |
| Gross margin | (510,513) | (795,900) | (874,359) | (1,493,899) |
| Operating expenses: | ||||
| Selling, general, and administrative expense | 11,202,485 | 873,299 | 25,288,394 | 1,345,881 |
| Research and development | 126,313 | — | 126,313 | — |
| Total operating expenses | 11,328,798 | 873,299 | 25,414,707 | 1,345,881 |
| Loss from operations | (11,839,311) | (1,669,199) | (26,289,066) | (2,839,780) |
| Other expense, net: | ||||
| Interest expense, net | (1,860,323) | (582,123) | (2,004,679) | (988,452) |
| Amortization of deferred financing costs | (191,590) | — | (191,590) | — |
| Change in fair value of warrant liability | 45,094 | — | 45,094 | — |
| Loss on sale of assets | (16,758) | (1,906) | (56,215) | (1,906) |
| Other income | — | 25,500 | — | 42,500 |
| Other expense | (13,389) | (10,260) | (26,776) | (20,525) |
| Total other expense, net | (2,036,966) | (568,789) | (2,234,166) | (968,383) |
| Net loss before income taxes | (13,876,277) | (2,237,988) | (28,523,232) | (3,808,163) |
| Income tax provision | — | — | — | — |
| Net loss | (13,876,277) | (2,237,988) | (28,523,232) | (3,808,163) |
| Net loss per share: | ||||
| Basic and diluted | (0.26) | (0.06) | (0.54) | (0.10) |
| Weighted average number of shares outstanding | ||||
| Basic and diluted | 54,112,845 | 37,784,611 | 52,767,635 | 37,784,611 |
Condensed Balance Sheets (Unaudited)
| Description | June 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current Assets | ||
| Cash | 4,923,504 | 2,477,122 |
| Accounts receivable | 26,584 | 51,889 |
| Inventories, net | 787,479 | 918,359 |
| Prepaid assets | 1,255,080 | 46,192 |
| Total Current Assets | 6,992,647 | 3,493,562 |
| Property and equipment, net | 9,258,482 | 8,201,957 |
| Right-of-use assets | 1,093,493 | 1,271,638 |
| Other assets | 273,622 | 53,625 |
| Total assets | 17,618,244 | 13,020,782 |
| Liabilities and stockholders’ equity | ||
| Current Liabilities | ||
| Accounts payable | 1,321,695 | 2,041,908 |
| Accrued liabilities | 413,216 | 431,659 |
| Accrued liabilities, related party | — | 428,278 |
| Employee loan payable, related party | 121,739 | 121,739 |
| Note payable related party | 50,000 | 50,000 |
| Note payable current portion | — | 7,166 |
| Convertible notes payable, net of debt discount current portion | 9,348,543 | 284,146 |
| Warrant liability, at fair value | 2,547,702 | — |
| Operating lease liability current portion | 387,521 | 372,665 |
| Financing lease liability current portion | 1,037,003 | 893,710 |
| Total current liabilities | 15,227,419 | 4,631,271 |
| Long-term liabilities: | ||
| Note payable | — | 27,523 |
| Convertible notes payable, net of debt discount | — | 201,215 |
| Operating lease liability net of current portion | 791,469 | 988,471 |
| Financing lease liability net of current portion | 229,697 | 767,822 |
| Total liabilities | 16,248,585 | 6,616,302 |
| Commitments and contingencies (Note 17) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 1,000,000 authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value, 500,000,000 and 100,000,000 authorized, 49,152,702 and 44,500,111 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively | 4,915 | 4,450 |
| Additional paid-in capital | 65,131,098 | 41,643,152 |
| Accumulated deficit | (63,766,354) | (35,243,122) |
| Total stockholders’ equity | 1,369,659 | 6,404,480 |
| Total liabilities and stockholders’ equity | 17,618,244 | 13,020,782 |
Condensed Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (28,523,232) | (3,808,163) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 21,962,399 | — |
| Issuance of stocks for services | 184,008 | — |
| Depreciation and amortization | 682,374 | 665,743 |
| Amortization of debt discount | 129,278 | 135,565 |
| Amortization of debt discount warrant feature and OID interest | 1,559,510 | 433,458 |
| Change in fair value of warrant liability | (45,094) | — |
| Amortization of deferred financing costs | 191,590 | — |
| Non-cash PIK interest | 30,393 | 143,731 |
| Loss on sale of asset | (56,215) | (1,906) |
| Right-of-use assets, net of lease liabilities | (4,001) | 2,146 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 25,305 | 11,825 |
| Inventories | 130,880 | 1,120,416 |
| Prepaid and other current assets | (1,208,888) | (14,985) |
| Accounts payable | (720,214) | 567,390 |
| Accrued liabilities | 330,703 | 234,508 |
| Accrued liabilities, related party | (428,278) | (6,200) |
| Contract liabilities | — | (54,410) |
| Net cash used in operating activities | (5,759,482) | (570,882) |
| Cash flows from investing activities: | ||
| Proceeds from sale of assets | — | 78,000 |
| Capitalized expenditures | (1,682,684) | (88,368) |
| Net cash used in investing activities | (1,682,684) | (10,368) |
| Cash flows from financing activities: | ||
| Proceeds from convertible notes payable | 10,150,000 | 1,350,000 |
| Principal payments on financing lease | (598,766) | (597,117) |
| Proceeds from issuance on equity offerings | 1,342,003 | — |
| Payments on note payable | (34,689) | (564) |
| Debt issuance and deferred direct listing costs | (970,000) | — |
| Net cash provided by financing activities | 9,888,548 | 752,319 |
| Net change to cash | 2,446,382 | 171,069 |
| Cash, beginning of period | 2,477,122 | 434,613 |
| Cash, end of period | 4,923,504 | 605,682 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | 203,009 | 262,496 |
| Supplemental non-cash financing activities | ||
| Original issue discount on debt | 5,465,385 | — |
| Warrant liabilities recognized as debt discounts | 2,592,796 | — |
| Issuance of warrants in conjunction with convertible notes payable | — | 586,813 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗